Literature DB >> 18700060

Update on the diagnosis and management of prostate cancer.

Mark LaSpina1, Gabriel P Haas.   

Abstract

Early detection of prostate adenocarcinoma (prostate cancer) through screening tests such as a serum prostate-specific antigen (PSA) test and a digital rectal examination (DRE) enables primary care physicians and urologists to offer patients a broader choice of treatments that are also more likely to provide a cure. Whether men are being over treated or over diagnosed through the widespread use of screening tests remains controversial. This review aims to provide general practitioners with a better understanding of different prostate cancer tests that can be performed and to help them decide which patients should be referred to a urologist for an ultrasound-guided biopsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700060

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  8 in total

1.  Abdominal and back pain in a 65-year-old patient with metastatic prostate cancer.

Authors:  Theodore L Johnson
Journal:  J Chiropr Med       Date:  2010-03

2.  Diagnosis and management of benign prostatic hyperplasia in primary care.

Authors:  Simon Tanguay; Murray Awde; Gerald Brock; Richard Casey; Joseph Kozak; Jay Lee; J Curtis Nickel; Fred Saad
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

3.  iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.

Authors:  Ishtiaq Rehman; Caroline A Evans; Adam Glen; Simon S Cross; Colby L Eaton; Jenny Down; Giancarlo Pesce; Joshua T Phillips; Ow Saw Yen; George N Thalmann; Phillip C Wright; Freddie C Hamdy
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

4.  Markers of field cancerization: proposed clinical applications in prostate biopsies.

Authors:  Kristina A Trujillo; Anna C Jones; Jeffrey K Griffith; Marco Bisoffi
Journal:  Prostate Cancer       Date:  2012-05-14

5.  NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells.

Authors:  Mithun Kailavasan; Ishtiaq Rehman; Steven Reynolds; Adriana Bucur; Gillian Tozer; Martyn Paley
Journal:  NMR Biomed       Date:  2014-03-17       Impact factor: 4.044

6.  Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer.

Authors:  Kay Sundberg; Yvonne Wengström; Karin Blomberg; Maria Hälleberg-Nyman; Catharina Frank; Ann Langius-Eklöf
Journal:  Support Care Cancer       Date:  2017-02-24       Impact factor: 3.603

7.  Multi-Task Learning for Registering Images With Large Deformation.

Authors:  Bo Du; Jiandong Liao; Baris Turkbey; Pingkun Yan
Journal:  IEEE J Biomed Health Inform       Date:  2021-05-11       Impact factor: 5.772

8.  Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.

Authors:  Tanya C Burch; Megan T Watson; Julius O Nyalwidhe
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.